Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels. Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
The recent increase in number of out-patient surgeries is the prime driver for the growth of this market. Since these surgeries help to reduce the overall healthcare expenditure, they are increasingly being preferred by insurance payers to acquire reimbursements for their surgeries. Furthermore, as the out-patient surgeries do not require overnight stays, they are readily available to the patients.
The increasing use of fibrin sealants for hemostats aids is an emerging trend in this market. The use of fibrin sealants helps in the rapid formation of a stable clot and can also be applied to small blood vessels and to the areas that are difficult to reach with conventional sutures. Since there is minimal blood loss involved in this process, the use of fibrin sealants will witness a rapid increase during the forecast period.

The global Hemostats and Tissue Sealants market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hemostats and Tissue Sealants volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemostats and Tissue Sealants market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hemostats and Tissue Sealants in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hemostats and Tissue Sealants manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Baxter
CR Bard
Johnson & Johnson
B.Braun
Cardinal Health
Cryolife
Neomend
Vivostat
Z-Medica

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Hemostats
Tissue Sealants

Segment by Application
Clinical Medicine
Scientific Research